{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:18:01Z","timestamp":1784557081939,"version":"3.55.0"},"reference-count":149,"publisher":"Bioscientifica","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["eor.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:p>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>\n                          Fibrodysplasia ossificans progressiva and progressive osseous heteroplasia are genetic forms of heterotopic ossification (HO). Fibrodysplasia ossificans progressiva is caused by\n                          <jats:italic>ACVR1<\/jats:italic>\n                          gene mutations, while progressive osseous heteroplasia is caused by\n                          <jats:italic>GNAS<\/jats:italic>\n                          gene mutations.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Nongenetic HO typically occurs after trauma or surgery, with an occurrence rate of 20\u201360%. It can also be observed in conditions such as diffuse idiopathic skeletal hyperostosis, spinal ligament ossification, ankylosing spondylitis, and skeletal fluorosis. The exact cause of nongenetic HO is not entirely clear.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>More than 100 types of miRNAs have been identified as being linked to the development of HO. Some miRNAs are promising potential biomarkers for traumatic HO and ossification of the posterior longitudinal ligament. These findings further emphasize the significant role miRNAs play in the pathogenesis and progression of bone disorders.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Repeated investigations into the function of a specific miRNA are infrequent and yield inconsistent results, possibly because of variable experimental conditions.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>It is hypothesized that miRNAs can enhance osteogenesis for the management of fractures and bone defects. However, further research is required to validate this hypothesis.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:p>","DOI":"10.1530\/eor-22-0100","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T07:42:25Z","timestamp":1733125345000},"page":"1120-1133","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":2,"title":["The role of miRNAs as biomarkers in heterotopic ossification"],"prefix":"10.1530","volume":"9","author":[{"given":"Chen","family":"Xie","sequence":"first","affiliation":[{"name":"Trauma center, The 960th Hospital of PLA, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, The 960th Hospital of PLA, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbao","family":"Li","sequence":"additional","affiliation":[{"name":"Trauma center, The 960th Hospital of PLA, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhe","family":"Yao","sequence":"additional","affiliation":[{"name":"Trauma center, The 960th Hospital of PLA, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyue","family":"Men","sequence":"additional","affiliation":[{"name":"Trauma center, The 960th Hospital of PLA, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-4273","authenticated-orcid":true,"given":"Zongyu","family":"Li","sequence":"additional","affiliation":[{"name":"Trauma center, The 960th Hospital of PLA, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Acta Biomaterialia","first-page":"1","article-title":"Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification","volume":"145","author":"Bohner","year":"2022","unstructured":"Bohner MMaazouz YGinebra MPHabibovic PSchoenecker JGSeeherman Hvan den Beucken JJJP & Witte F. Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification. Acta Biomaterialia 2022 145 1\u201324. (https:\/\/doi.org\/10.1016\/j.actbio.2022.03.057)"},{"key":"bib2","series-title":"JBMR Plus","first-page":"e10172","article-title":"Heterotopic ossification: a comprehensive review","volume":"3","author":"Meyers","year":"2019","unstructured":"Meyers CLisiecki JMiller SLevin AFayad LDing CSono TMcCarthy ELevi B & James AW. Heterotopic ossification: a comprehensive review. JBMR Plus 2019 3 e10172. (https:\/\/doi.org\/10.1002\/jbm4.10172)"},{"key":"bib3","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","article-title":"miRNA biogenesis and regulation of diseases: an updated overview","volume":"2595","author":"Vishnoi","year":"2023","unstructured":"Vishnoi A & Rani S. miRNA biogenesis and regulation of diseases: an updated overview. Methods in Molecular Biology 2023 2595 1\u201312. (https:\/\/doi.org\/10.1007\/978-1-0716-2823-2_1)"},{"key":"bib4","series-title":"Nucleic Acids Research","first-page":"617","article-title":"Reexamining assumptions about miRNA-guided gene silencing","volume":"50","author":"Kilikevicius","year":"2022","unstructured":"Kilikevicius AMeister G & Corey DR. Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Research 2022 50 617\u2013634. (https:\/\/doi.org\/10.1093\/nar\/gkab1256)"},{"key":"bib5","series-title":"Injury","first-page":"111410","article-title":"MicroRNAs in osteoblast differentiation and fracture healing: from pathogenesis to therapeutic implication","volume":"55","author":"Yao","year":"2024","unstructured":"Yao JXin RZhao C & Yu C. MicroRNAs in osteoblast differentiation and fracture healing: from pathogenesis to therapeutic implication. Injury 2024 55 111410. (https:\/\/doi.org\/10.1016\/j.injury.2024.111410)"},{"key":"bib6","series-title":"Biological Research","first-page":"40","article-title":"The roles of miRNA, lncRNA and circRNA in the development of osteoporosis","volume":"53","author":"Yang","year":"2020","unstructured":"Yang YYujiao WFang WLinhui YZiqi GZhichen WZirui W & Shengwang W. The roles of miRNA, lncRNA and circRNA in the development of osteoporosis. Biological Research 2020 53 40. (https:\/\/doi.org\/10.1186\/s40659-020-00309-z)"},{"key":"bib7","series-title":"Genes","first-page":"2162","article-title":"Navigating the complex landscape of fibrodysplasia ossificans progressiva: from current paradigms to therapeutic frontiers","volume":"14","author":"Anwar","year":"2023","unstructured":"Anwar S & Yokota T. Navigating the complex landscape of fibrodysplasia ossificans progressiva: from current paradigms to therapeutic frontiers. Genes 2023 14 2162. (https:\/\/doi.org\/10.3390\/genes14122162)"},{"key":"bib8","series-title":"Orthopedic Research and Reviews","first-page":"113","article-title":"Monitoring and management of fibrodysplasia ossificans progressiva: current perspectives","volume":"14","author":"Smilde","year":"2022","unstructured":"Smilde BJBotman Ede Ruiter RDSmit JMTeunissen BPLubbers WDSchwarte LASchober P & Eekhoff EMW. Monitoring and management of fibrodysplasia ossificans progressiva: current perspectives. Orthopedic Research and Reviews 2022 14 113\u2013120. (https:\/\/doi.org\/10.2147\/ORR.S337491) Erratum in: Orthopedic Research and Reviews 2022 14 147\u2013148. (https:\/\/doi.org\/10.2147\/ORR.S337491)]"},{"key":"bib9","series-title":"Frontiers in Endocrinology","first-page":"908","article-title":"Fibrodysplasia ossificans progressiva (FOP): a segmental progeroid syndrome","volume":"10","author":"Pignolo","year":"2019","unstructured":"Pignolo RJWang H & Kaplan FS. Fibrodysplasia ossificans progressiva (FOP): a segmental progeroid syndrome. Frontiers in Endocrinology 2019 10 908. (https:\/\/doi.org\/10.3389\/fendo.2019.00908)"},{"key":"bib10","series-title":"Developmental Dynamics","first-page":"164","article-title":"BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP)","volume":"251","author":"Towler","year":"2022","unstructured":"Towler OW & Shore EM. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Developmental Dynamics 2022 251 164\u2013177. (https:\/\/doi.org\/10.1002\/dvdy.387)"},{"key":"bib11","series-title":"Rheumatology International","first-page":"569","article-title":"Challenges in the treatment of fibrodysplasia ossificans progressiva","volume":"39","author":"Gencer-Atalay","year":"2019","unstructured":"Gencer-Atalay KOzturk ECYagci IAta PDelil KOzgen Z & Akyuz G. Challenges in the treatment of fibrodysplasia ossificans progressiva. Rheumatology International 2019 39 569\u2013576. (https:\/\/doi.org\/10.1007\/s00296-018-4179-x)"},{"key":"bib12","series-title":"Human Gene Therapy","first-page":"782","article-title":"Gene therapy for fibrodysplasia ossificans progressiva: feasibility and obstacles","volume":"33","author":"Eekhoff","year":"2022","unstructured":"Eekhoff EMWde Ruiter RDSmilde BJSchoenmaker Tde Vries TJNetelenbos CHsiao ECScott CHaga NGrunwald Z, et al. Gene therapy for fibrodysplasia ossificans progressiva: feasibility and obstacles. Human Gene Therapy 2022 33 782\u2013788. (https:\/\/doi.org\/10.1089\/hum.2022.023)"},{"key":"bib13","series-title":"Human Mutation","first-page":"379","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","unstructured":"Kaplan FSXu MSeemann PConnor JMGlaser DLCarroll LDelai PFastnacht-Urban EForman SJGillessen-Kaesbach G, et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Human Mutation 2009 30 379\u2013390. (https:\/\/doi.org\/10.1002\/humu.20868)"},{"key":"bib14","series-title":"Frontiers in Endocrinology","first-page":"570","article-title":"When limb surgery has become the only life-saving therapy in FOP: A case report and systematic review of the literature","volume":"11","author":"Botman","year":"2020","unstructured":"Botman ETreurniet SLubbers WDSchwarte LASchober PRSabelis LPeters EJGvan Schie Ade Vries RGrunwald Z, et al. When limb surgery has become the only life-saving therapy in FOP: A case report and systematic review of the literature. Frontiers in Endocrinology 2020 11 570. (https:\/\/doi.org\/10.3389\/fendo.2020.00570)"},{"key":"bib15","series-title":"Thoracic and Cardiovascular Surgeon","first-page":"192","article-title":"Intrathoracic fibrodysplasia ossificans progressiva","volume":"62","author":"\u00d6zkan","year":"2014","unstructured":"\u00d6zkan SAlp EDemira\u011f FYaz\u0131c\u0131 \u00dc & Karao\u011flano\u011flu N. Intrathoracic fibrodysplasia ossificans progressiva. Thoracic and Cardiovascular Surgeon 2014 62 192\u2013195. (https:\/\/doi.org\/10.1055\/s-0032-1322622)"},{"key":"bib16","series-title":"Annals of Thoracic and Cardiovascular Surgery","first-page":"61","article-title":"Surgical treatment combined with NSAIDs in fibrodysplasia ossificans progressiva","volume":"18","author":"Seok","year":"2012","unstructured":"Seok YCho S & Lee E. Surgical treatment combined with NSAIDs in fibrodysplasia ossificans progressiva. Annals of Thoracic and Cardiovascular Surgery 2012 18 61\u201363. (https:\/\/doi.org\/10.5761\/atcs.cr.11.01677)"},{"key":"bib17","series-title":"Journal of Oral and Maxillofacial Surgery","first-page":"1408","article-title":"Intraoral approach technique for treating trismus caused by fibrodysplasia ossificans progressiva","volume":"68","author":"Duan","year":"2010","unstructured":"Duan YZhang H & Bu R. Intraoral approach technique for treating trismus caused by fibrodysplasia ossificans progressiva. Journal of Oral and Maxillofacial Surgery 2010 68 1408\u20131410. (https:\/\/doi.org\/10.1016\/j.joms.2009.11.005)"},{"key":"bib18","series-title":"Journal of Bone and Joint Surgery","first-page":"1497","article-title":"Chin-on-chest deformity in patients with fibrodysplasia ossificans progressiva: a case series","volume":"91","author":"Moore","year":"2009","unstructured":"Moore REDormans JPDrummond DSShore EMKaplan FS & Auerbach JD. Chin-on-chest deformity in patients with fibrodysplasia ossificans progressiva: a case series. Journal of Bone and Joint Surgery 2009 91 1497\u20131502. (https:\/\/doi.org\/10.2106\/JBJS.H.00554)"},{"key":"bib19","unstructured":"Available at: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-treatment-fibrodysplasia-ossificans-progressiva."},{"key":"bib20","series-title":"Nature Medicine","first-page":"2615","article-title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"29","author":"Di Rocco","year":"2023","unstructured":"Di Rocco MForleo-Neto EPignolo RJKeen ROrcel PFunck-Brentano TRoux CKolta SMadeo ABubbear JS, et al. Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial. Nature Medicine 2023 29 2615\u20132624. (https:\/\/doi.org\/10.1038\/s41591-023-02561-8)"},{"key":"bib21","series-title":"Bone","first-page":"281","article-title":"Acute and chronic rapamycin use in patients with fibrodysplasia ossificans progressiva: A report of two cases","volume":"109","author":"Kaplan","year":"2018","unstructured":"Kaplan FSZeitlin LDunn SPBenor SHagin DAl Mukaddam M & Pignolo RJ. Acute and chronic rapamycin use in patients with fibrodysplasia ossificans progressiva: A report of two cases. Bone 2018 109 281\u2013284. (https:\/\/doi.org\/10.1016\/j.bone.2017.12.011)"},{"key":"bib22","series-title":"JCI Insight","first-page":"e95042","article-title":"Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva","volume":"6","author":"Williams","year":"2021","unstructured":"Williams EBagarova JKerr GXia DDPlace ESDey DShen YBocobo GAMohedas AHHuang X, et al. Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva. JCI Insight 2021 6 e95042. (https:\/\/doi.org\/10.1172\/jci.insight.95042)"},{"key":"bib23","series-title":"PLoS One","first-page":"e50958","article-title":"The role of the 3'UTR region in the regulation of the ACVR1\/Alk-2 gene expression","volume":"7","author":"Mura","year":"2012","unstructured":"Mura MCappato SGiacopelli FRavazzolo R & Bocciardi R. The role of the 3'UTR region in the regulation of the ACVR1\/Alk-2 gene expression. PLoS One 2012 7 e50958. (https:\/\/doi.org\/10.1371\/journal.pone.0050958)"},{"key":"bib24","series-title":"International Journal of Molecular Sciences","first-page":"2063","article-title":"ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a","volume":"13","author":"Song","year":"2012","unstructured":"Song HWang QWen JLiu SGao XCheng J & Zhang D. ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a. International Journal of Molecular Sciences 2012 13 2063\u20132077. (https:\/\/doi.org\/10.3390\/ijms13022063)"},{"key":"bib25","series-title":"Nature Communications","first-page":"6175","article-title":"Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery","volume":"13","author":"Yang","year":"2022","unstructured":"Yang YSKim JMXie JChaugule SLin CMa HHsiao EHong JChun HShore EM, et al. Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. Nature Communications 2022 13 6175. (https:\/\/doi.org\/10.1038\/s41467-022-33956-9)"},{"key":"bib26","series-title":"Biomolecules","first-page":"1364","article-title":"AAV-mediated targeting of the activin A-ACVR1R206H signaling in fibrodysplasia ossificans progressiva","volume":"13","author":"Yang","year":"2023","unstructured":"Yang YSLin CMa HXie JKaplan FSGao G & Shim JH. AAV-mediated targeting of the activin A-ACVR1R206H signaling in fibrodysplasia ossificans progressiva. Biomolecules 2023 13 1364. (https:\/\/doi.org\/10.3390\/biom13091364)"},{"key":"bib27","series-title":"Nature Reviews","first-page":"518","article-title":"Inherited human diseases of heterotopic bone formation","volume":"6","author":"Shore","year":"2010","unstructured":"Shore EM & Kaplan FS. Inherited human diseases of heterotopic bone formation. Nature Reviews 2010 6 518\u2013527. (https:\/\/doi.org\/10.1038\/nrrheum.2010.122)"},{"issue":"317","key":"bib28","series-title":"Clinical Orthopaedics and Related Research","first-page":"243","article-title":"Progressive osseous heteroplasia in male patients: two new case reports","author":"Rosenfeld","year":"1995","unstructured":"Rosenfeld SR & Kaplan FS. Progressive osseous heteroplasia in male patients: two new case reports. Clinical Orthopaedics and Related Research 1995 (317) 243\u2013245."},{"key":"bib29","series-title":"Journal of Clinical Investigation","first-page":"3624","article-title":"Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia","volume":"123","author":"Cairns","year":"2013","unstructured":"Cairns DMPignolo RJUchimura TBrennan TALindborg CMXu MKaplan FSShore EM & Zeng L. Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia. Journal of Clinical Investigation 2013 123 3624\u20133633. (https:\/\/doi.org\/10.1172\/JCI69746) Erratum in: Journal of Clinical Investigation 2013 123 4981. (https:\/\/doi.org\/10.1172\/JCI69746) Erratum in: Journal of Clinical Investigation 2013 123 4981. (https:\/\/doi.org\/10.1172\/JCI69746)"},{"key":"bib30","series-title":"Frontiers in Endocrinology","first-page":"1255864","article-title":"GNAS locus: bone related diseases and mouse models","volume":"14","author":"Yang","year":"2023","unstructured":"Yang WZuo YZhang NWang KZhang RChen Z & He Q. GNAS locus: bone related diseases and mouse models. Frontiers in Endocrinology 2023 14 1255864. (https:\/\/doi.org\/10.3389\/fendo.2023.1255864)"},{"key":"bib31","series-title":"BMC Musculoskeletal Disorders","first-page":"247","article-title":"Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review","volume":"24","author":"Ma","year":"2023","unstructured":"Ma JMo WSun JLi YHan T & Mao H. Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review. BMC Musculoskeletal Disorders 2023 24 247. (https:\/\/doi.org\/10.1186\/s12891-023-06371-4)"},{"key":"bib32","series-title":"American Journal of Medical Genetics","first-page":"1788","article-title":"Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification","volume":"146A","author":"Adegbite","year":"2008","unstructured":"Adegbite NSXu MKaplan FSShore EM & Pignolo RJ. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. American Journal of Medical Genetics 2008 146A 1788\u20131796. (https:\/\/doi.org\/10.1002\/ajmg.a.32346)"},{"key":"bib33","series-title":"Bone","first-page":"80","article-title":"GNAS mutations and heterotopic ossification","volume":"109","author":"Bastepe","year":"2018","unstructured":"Bastepe M. GNAS mutations and heterotopic ossification. Bone 2018 109 80\u201385. (https:\/\/doi.org\/10.1016\/j.bone.2017.09.002)"},{"key":"bib34","series-title":"American Journal of Translational Research","first-page":"14109","article-title":"Progressive osseous heteroplasia: a case report and literature review","volume":"13","author":"Zhang","year":"2021","unstructured":"Zhang KTang HZhang RWang YSu QLin XTian QCao SFu MZhu J, et al. Progressive osseous heteroplasia: a case report and literature review. American Journal of Translational Research 2021 13 14109\u201314114."},{"key":"bib35","series-title":"Indian Dermatology Online Journal","first-page":"316","article-title":"Progressive osseous heteroplasia is not an autosomal dominant trait but reflects superimposed mosaicism in different GNAS inactivation disorders","volume":"12","author":"Happle","year":"2021","unstructured":"Happle R. Progressive osseous heteroplasia is not an autosomal dominant trait but reflects superimposed mosaicism in different GNAS inactivation disorders. Indian Dermatology Online Journal 2021 12 316\u2013318. (https:\/\/doi.org\/10.4103\/idoj.IDOJ_584_20)"},{"key":"bib36","series-title":"Calcified Tissue International","first-page":"212","article-title":"The distinct role of the extra-large G protein \u0251-subunit XL\u0251s","volume":"107","author":"Wang","year":"2020","unstructured":"Wang YTian H & Chen X. The distinct role of the extra-large G protein \u0251-subunit XL\u0251s. Calcified Tissue International 2020 107 212\u2013219. (https:\/\/doi.org\/10.1007\/s00223-020-00714-2)"},{"key":"bib37","series-title":"Clinical Genetics","first-page":"279","article-title":"GNAS gene mutations affecting XL\u03b1s and bone health: a long neglected relationship","volume":"104","author":"Xie","year":"2023","unstructured":"Xie YChen XXie Y & Yu X. GNAS gene mutations affecting XL\u03b1s and bone health: a long neglected relationship. Clinical Genetics 2023 104 279\u2013286. (https:\/\/doi.org\/10.1111\/cge.14378)"},{"key":"bib38","series-title":"Journal of Bone and Mineral Research","first-page":"2084","article-title":"Progressive osseous heteroplasia","volume":"15","author":"Kaplan","year":"2000","unstructured":"Kaplan FS & Shore EM. Progressive osseous heteroplasia. Journal of Bone and Mineral Research 2000 15 2084\u20132094. (https:\/\/doi.org\/10.1359\/jbmr.2000.15.11.2084)"},{"key":"bib39","series-title":"Bone","first-page":"12","article-title":"Heterotopic ossification and the elucidation of pathologic differentiation","volume":"109","author":"Cholok","year":"2018","unstructured":"Cholok DChung MTRanganathan KUcer SDay DDavis TAMishina Y & Levi B. Heterotopic ossification and the elucidation of pathologic differentiation. Bone 2018 109 12\u201321. (https:\/\/doi.org\/10.1016\/j.bone.2017.09.019)"},{"key":"bib40","series-title":"Journal of Bone and Joint Surgery","first-page":"907","article-title":"Hemimelic progressive osseous heteroplasia: a case report","volume":"76","author":"Schmidt","year":"1994","unstructured":"Schmidt AHVincent KA & Aiona MD. Hemimelic progressive osseous heteroplasia: a case report. Journal of Bone and Joint Surgery 1994 76 907\u2013912. (https:\/\/doi.org\/10.2106\/00004623-199406000-00016)"},{"key":"bib41","series-title":"Bone Reports","first-page":"101665","article-title":"Progressive osseous heteroplasia: a case report with an unexpected trigger","volume":"18","author":"Boncompagni","year":"2023","unstructured":"Boncompagni ALucas-Herald AKBeattie PMcDevitt HIughetti LConstantinou PKinning EAhmed SF & Mason A. Progressive osseous heteroplasia: a case report with an unexpected trigger. Bone Reports 2023 18 101665. (https:\/\/doi.org\/10.1016\/j.bonr.2023.101665)"},{"key":"bib42","series-title":"Frontiers in Pediatrics","first-page":"936780","article-title":"Case report: everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia","volume":"10","author":"Cebey-L\u00f3pez","year":"2022","unstructured":"Cebey-L\u00f3pez MCurr\u00e1s-Tuala MJG\u00f3mez-Rial JRivero-Calle IPardo-Seco JMendez-Gallart RPischedda SG\u00f3mez-Carballa ABarral-Arca RJusticia-Grande A, et al. Case report: everolimus reduced bone turnover markers but showed no clinical benefit in a patient with severe progressive osseous heteroplasia. Frontiers in Pediatrics 2022 10 936780. (https:\/\/doi.org\/10.3389\/fped.2022.936780)"},{"key":"bib43","series-title":"American Journal of Medical Genetics","first-page":"910","article-title":"Progressive osseous heteroplasia controlled by intravenous administration of pamidronate","volume":"140","author":"Hou","year":"2006","unstructured":"Hou JW. Progressive osseous heteroplasia controlled by intravenous administration of pamidronate. American Journal of Medical Genetics 2006 140 910\u2013913. (https:\/\/doi.org\/10.1002\/ajmg.a.31200)"},{"key":"bib44","series-title":"Genes and Diseases","first-page":"100981","article-title":"Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia","volume":"11","author":"G\u00f3mez-Carballa","year":"2024","unstructured":"G\u00f3mez-Carballa ACurr\u00e1s-Tuala MJPischedda SCebey-L\u00f3pez MG\u00f3mez-Rial JRivero-Calle IPardo-Seco JBello XViz-Lasheras SJusticia-Grande A, et al. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia. Genes and Diseases 2024 11 100981. (https:\/\/doi.org\/10.1016\/j.gendis.2023.05.001)"},{"key":"bib45","series-title":"Journal of Biological Chemistry","first-page":"27745","article-title":"MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1","volume":"285","author":"Itoh","year":"2010","unstructured":"Itoh TTakeda S & Akao Y. MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1. Journal of Biological Chemistry 2010 285 27745\u201327752. (https:\/\/doi.org\/10.1074\/jbc.M110.105080)"},{"key":"bib46","series-title":"Cellular and Molecular Biology","first-page":"113","article-title":"Circular RNA circ_0096041 promotes osteosarcoma cell proliferation and migration via sponging miR-556-5p and regulating LIN28A expression","volume":"70","author":"Zhou","year":"2024","unstructured":"Zhou FWu HYin ZZhou W & Chen W. Circular RNA circ_0096041 promotes osteosarcoma cell proliferation and migration via sponging miR-556-5p and regulating LIN28A expression. Cellular and Molecular Biology 2024 70 113\u2013119. (https:\/\/doi.org\/10.14715\/cmb\/2024.70.2.16)"},{"key":"bib47","series-title":"Oncology Letters","first-page":"8149","article-title":"MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1","volume":"15","author":"Qian","year":"2018","unstructured":"Qian MGong HYang XZhao JYan WLou YPeng DLi Z & Xiao J. MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1. Oncology Letters 2018 15 8149\u20138156. (https:\/\/doi.org\/10.3892\/ol.2018.8268)"},{"key":"bib48","series-title":"Current Environmental Health Reports","first-page":"140","article-title":"Fluoride in drinking water and skeletal fluorosis: a review of the global Impact","volume":"7","author":"Srivastava","year":"2020","unstructured":"Srivastava S & Flora SJS. Fluoride in drinking water and skeletal fluorosis: a review of the global Impact. Current Environmental Health Reports: 2020 7 140\u2013146. (https:\/\/doi.org\/10.1007\/s40572-020-00270-9)"},{"key":"bib49","series-title":"Clinical Nuclear Medicine","first-page":"1127","article-title":"Skeletal fluorosis","volume":"48","author":"Gerges","year":"2023","unstructured":"Gerges MMNgo VTTu JColletti PM & Wassef H. Skeletal fluorosis. Clinical Nuclear Medicine 2023 48 1127\u20131130. (https:\/\/doi.org\/10.1097\/RLU.0000000000004911)"},{"key":"bib50","series-title":"Critical Reviews in Clinical Laboratory Sciences","first-page":"139","article-title":"Fluoride and the skeleton","volume":"33","author":"Kleerekoper","year":"1996","unstructured":"Kleerekoper M. Fluoride and the skeleton. Critical Reviews in Clinical Laboratory Sciences 1996 33 139\u2013161. (https:\/\/doi.org\/10.3109\/10408369609083059)"},{"key":"bib51","series-title":"Skeletal Radiology","first-page":"345","article-title":"Skeletal fluorosis: don't miss the diagnosis!","volume":"49","author":"Sellami","year":"2020","unstructured":"Sellami MRiahi HMaatallah KFerjani HBouaziz MC & Ladeb MF. Skeletal fluorosis: don't miss the diagnosis! Skeletal Radiology 2020 49 345\u2013357. (https:\/\/doi.org\/10.1007\/s00256-019-03302-0)"},{"key":"bib52","series-title":"Schweizerische Medizinische Wochenschrift","first-page":"2228","article-title":"Fluor in the treatment of osteoporosis: an overview of thirty years clinical research","volume":"123","author":"Dequeker","year":"1993","unstructured":"Dequeker J & Declerck K. Fluor in the treatment of osteoporosis: an overview of thirty years clinical research. Schweizerische Medizinische Wochenschrift 1993 123 2228\u20132234."},{"key":"bib53","series-title":"Osteoporosis International","first-page":"257","article-title":"Effects of treatment with fluoride on bone mineral density and fracture risk: a meta-analysis","volume":"19","author":"Vestergaard","year":"2008","unstructured":"Vestergaard PJorgensen NRSchwarz P & Mosekilde L. Effects of treatment with fluoride on bone mineral density and fracture risk: a meta-analysis. Osteoporosis International 2008 19 257\u2013268. (https:\/\/doi.org\/10.1007\/s00198-007-0437-6)"},{"key":"bib54","series-title":"American Journal of Roentgenology","first-page":"93","article-title":"Endemic fluorosis of the skeleton: radiographic features in 127 patients","volume":"162","author":"Wang","year":"1994","unstructured":"Wang YYin YGilula LA & Wilson AJ. Endemic fluorosis of the skeleton: radiographic features in 127 patients. American Journal of Roentgenology 1994 162 93\u201398. (https:\/\/doi.org\/10.2214\/ajr.162.1.8273699)"},{"key":"bib55","series-title":"Biomedical and Environmental Sciences","first-page":"147","article-title":"Treatment and prevention of skeletal fluorosis","volume":"30","author":"Yang","year":"2017","unstructured":"Yang CWang Y & Xu H. Treatment and prevention of skeletal fluorosis. Biomedical and Environmental Sciences 2017 30 147\u2013149. (https:\/\/doi.org\/10.3967\/bes2017.020)"},{"key":"bib56","series-title":"Anatomical Record","first-page":"359","article-title":"Preliminary screening of fluorine-stained osteoblastic apoptosis-related microRNA","volume":"305","author":"Deng","year":"2022","unstructured":"Deng QYang JZhouyang JSheng WGao SZhang YHaopeng LBingxin B & Mengting W. Preliminary screening of fluorine-stained osteoblastic apoptosis-related microRNA. Anatomical Record 2022 305 359\u2013372. (https:\/\/doi.org\/10.1002\/ar.24709)"},{"key":"bib57","series-title":"Chemosphere","first-page":"694","article-title":"Identification of miR-200c-3p as a major regulator of SaoS2 cells activation induced by fluoride","volume":"199","author":"Jiang","year":"2018","unstructured":"Jiang YYang YWang HDarko GMSun D & Gao Y. Identification of miR-200c-3p as a major regulator of SaoS2 cells activation induced by fluoride. Chemosphere 2018 199 694\u2013701. (https:\/\/doi.org\/10.1016\/j.chemosphere.2018.01.095)"},{"key":"bib58","series-title":"Toxicology","first-page":"153079","article-title":"miR-21-5p and canonical Wnt signaling pathway promote osteoblast function through a feed-forward loop induced by fluoride","volume":"466","author":"Guo","year":"2022","unstructured":"Guo NYu YChu YLou QHuang WWu LFan CSu MZhang MYin F, et al. miR-21-5p and canonical Wnt signaling pathway promote osteoblast function through a feed-forward loop induced by fluoride. Toxicology 2022 466 153079. (https:\/\/doi.org\/10.1016\/j.tox.2021.153079)"},{"key":"bib59","series-title":"Bulletin of Environmental Contamination and Toxicology","first-page":"56","article-title":"Analysis of the microRNA profile of coal-burning endemic fluorosis using deep sequencing and bioinformatic approaches","volume":"103","author":"Wang","year":"2019","unstructured":"Wang FLi CQin YHan XGao JZhang ALuo P & Pan X. Analysis of the microRNA profile of coal-burning endemic fluorosis using deep sequencing and bioinformatic approaches. Bulletin of Environmental Contamination and Toxicology 2019 103 56\u201363. (https:\/\/doi.org\/10.1007\/s00128-019-02660-8)"},{"key":"bib60","series-title":"Journal of Trace Elements in Medicine and Biology: Organ of the Society for Minerals and Trace Elements","first-page":"126626","article-title":"Downregulation of miR-4755-5p promotes fluoride-induced osteoblast activation via tageting cyclin D1","volume":"62","author":"Gao","year":"2020","unstructured":"Gao JQin YLuo KWang XYu CZhang A & Pan X. Downregulation of miR-4755-5p promotes fluoride-induced osteoblast activation via tageting cyclin D1. Journal of Trace Elements in Medicine and Biology: Organ of the Society for Minerals and Trace Elements 2020 62 126626. (https:\/\/doi.org\/10.1016\/j.jtemb.2020.126626)"},{"key":"bib61","series-title":"Biological Trace Element Research","first-page":"1215","article-title":"miR-122-5p mediates fluoride-induced osteoblast activation by targeting CDK4","volume":"199","author":"Li","year":"2021","unstructured":"Li CQin YOuyang TYao MZhang ALuo P & Pan X. miR-122-5p mediates fluoride-induced osteoblast activation by targeting CDK4. Biological Trace Element Research 2021 199 1215\u20131227. (https:\/\/doi.org\/10.1007\/s12011-020-02239-z)"},{"key":"bib62","series-title":"Toxicological Sciences","first-page":"275","article-title":"Let-7c-5p regulates cyclinD1 in fluoride-mediated osteoblast proliferation and activation","volume":"182","author":"Luo","year":"2021","unstructured":"Luo KQin YOuyang TWang XZhang ALuo P & Pan X. Let-7c-5p regulates cyclinD1 in fluoride-mediated osteoblast proliferation and activation. Toxicological Sciences 2021 182 275\u2013287. (https:\/\/doi.org\/10.1093\/toxsci\/kfab054)"},{"key":"bib63","series-title":"Environmental Toxicology","first-page":"1817","article-title":"miR-486-3p regulates cyclinD1 and promotes fluoride-induced osteoblast proliferation and activation","volume":"36","author":"Ouyang","year":"2021","unstructured":"Ouyang TQin YLuo KHan XYu CZhang A & Pan X. miR-486-3p regulates cyclinD1 and promotes fluoride-induced osteoblast proliferation and activation. Environmental Toxicology 2021 36 1817\u20131828. (https:\/\/doi.org\/10.1002\/tox.23302)"},{"key":"bib64","series-title":"Current Osteoporosis Reports","first-page":"552","article-title":"Genetics of diffuse idiopathic skeletal hyperostosis and ossification of the spinal ligaments","volume":"21","author":"Kato","year":"2023","unstructured":"Kato HBraddock DT & Ito N. Genetics of diffuse idiopathic skeletal hyperostosis and ossification of the spinal ligaments. Current Osteoporosis Reports 2023 21 552\u2013566. (https:\/\/doi.org\/10.1007\/s11914-023-00814-6)"},{"key":"bib65","series-title":"Orthopedic Nursing","first-page":"375","article-title":"Diffuse idiopathic skeletal hyperostosis: Forestier\u2019s disease","volume":"23","author":"Childs","year":"2004","unstructured":"Childs SG. Diffuse idiopathic skeletal hyperostosis: Forestier\u2019s disease. Orthopedic Nursing 2004 23 375\u2013382; quiz 383\u2013384. (https:\/\/doi.org\/10.1097\/00006416-200411000-00006)"},{"key":"bib66","series-title":"Skeletal Radiology","first-page":"222","article-title":"The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations","volume":"26","author":"Weinfeld","year":"1997","unstructured":"Weinfeld RMOlson PNMaki DD & Griffiths HJ. The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiology 1997 26 222\u2013225. (https:\/\/doi.org\/10.1007\/s002560050225)"},{"key":"bib67","series-title":"StatPearls","first-page":"2024","article-title":"Diffuse idiopathic skeletal hyperostosis","author":"Luo","year":"2023","unstructured":"Luo TD & Varacallo M. Diffuse idiopathic skeletal hyperostosis. StatPearls [Internet]. In Treasure Island,FL: StatPearls Publishing 2023, p. 2024."},{"key":"bib68","series-title":"North American Spine Society Journal","first-page":"100312","article-title":"The prevalence of vertebral fractures in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis: a systematic review and meta-analysis","volume":"17","author":"Harlianto","year":"2024","unstructured":"Harlianto NIEzzafzafi SFoppen WKuperus JSvan der Horst-Bruinsma IEde Jong PA & Verlaan JJ. The prevalence of vertebral fractures in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis: a systematic review and meta-analysis. North American Spine Society Journal 2024 17 100312. (https:\/\/doi.org\/10.1016\/j.xnsj.2024.100312)"},{"issue":"Supplement 3","key":"bib69","series-title":"Surgical Neurology International","first-page":"S122","article-title":"Diffuse idiopathic skeletal hyperostosis: a review","volume":"5","author":"Nascimento","year":"2014","unstructured":"Nascimento FAGatto LAMLages RONeto HMDemartini Z & Koppe GL. Diffuse idiopathic skeletal hyperostosis: a review. Surgical Neurology International 2014 5(Supplement 3) S122\u2013S125. (https:\/\/doi.org\/10.4103\/2152-7806.130675)"},{"key":"bib70","series-title":"International Journal of Paleopathology","first-page":"45","article-title":"A recording form for differential diagnosis of arthropathies","volume":"20","author":"Ventades","year":"2018","unstructured":"Ventades NGLaza IMHervella M & de-la-R\u00faa C. A recording form for differential diagnosis of arthropathies. International Journal of Paleopathology 2018 20 45\u201349. (https:\/\/doi.org\/10.1016\/j.ijpp.2018.01.004)"},{"key":"bib71","series-title":"Nature Reviews","first-page":"741","article-title":"Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms","volume":"9","author":"Mader","year":"2013","unstructured":"Mader RVerlaan JJ & Buskila D. Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms. Nature Reviews 2013 9 741\u2013750. (https:\/\/doi.org\/10.1038\/nrrheum.2013.165)"},{"key":"bib72","series-title":"Annals of Medicine and Surgery","first-page":"103120","article-title":"Anterior cervical spine surgery for treatment of secondary dysphagia associated with cervical myelopathy in patient with Forestier\u2019s disease","volume":"72","author":"Liawrungrueang","year":"2021","unstructured":"Liawrungrueang WSarasombath PMaihom TTantivorawit WSugandhavesa N & Bunmaprasert T. Anterior cervical spine surgery for treatment of secondary dysphagia associated with cervical myelopathy in patient with Forestier\u2019s disease. Annals of Medicine and Surgery 2021 72 103120. (https:\/\/doi.org\/10.1016\/j.amsu.2021.103120)"},{"key":"bib73","series-title":"International Journal of Molecular Sciences","first-page":"4255","article-title":"Diffuse idiopathic skeletal hyperostosis of cervical spine with dysphagia-molecular and clinical aspects","volume":"22","author":"D\u0105browski","year":"2021","unstructured":"D\u0105browski M & Kubaszewski \u0141. Diffuse idiopathic skeletal hyperostosis of cervical spine with dysphagia-molecular and clinical aspects. International Journal of Molecular Sciences 2021 22 4255. (https:\/\/doi.org\/10.3390\/ijms22084255)"},{"key":"bib74","series-title":"Spine","first-page":"2321","article-title":"COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese","volume":"30","author":"Tsukahara","year":"2005","unstructured":"Tsukahara SMiyazawa NAkagawa HForejtova SPavelka KTanaka TToh STajima AAkiyama I & Inoue I. COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese. Spine 2005 30 2321\u20132324. (https:\/\/doi.org\/10.1097\/01.brs.0000182318.47343.6d)"},{"key":"bib75","series-title":"Acta Reumatol\u00f3gica Portuguesa","first-page":"116","article-title":"Whole exome sequencing of patients with diffuse idiopathic skeletal hyperostosis and calcium pyrophosphate crystal chondrocalcinosis","volume":"45","author":"Parreira","year":"2020","unstructured":"Parreira BCouto ARRocha FSousa MFaustino VPower DM & Bruges-Armas J. Whole exome sequencing of patients with diffuse idiopathic skeletal hyperostosis and calcium pyrophosphate crystal chondrocalcinosis. Acta Reumatol\u00f3gica Portuguesa 2020 45 116\u2013126."},{"key":"bib76","series-title":"Human Genome Variation","first-page":"17041","article-title":"Combined approach for finding susceptibility genes in DISH\/chondrocalcinosis families: whole-genome-wide linkage and IBS\/IBD studies","volume":"4","author":"Couto","year":"2017","unstructured":"Couto ARParreira BThomson RSoares MPower DMStankovich JArmas JB & Brown MA. Combined approach for finding susceptibility genes in DISH\/chondrocalcinosis families: whole-genome-wide linkage and IBS\/IBD studies. Human Genome Variation 2017 4 17041. (https:\/\/doi.org\/10.1038\/hgv.2017.41)"},{"key":"bib77","series-title":"Surgical Neurology International","first-page":"297","article-title":"A brief human history of ankylosing spondylitis: a scoping review of pathogenesis, diagnosis, and treatment","volume":"13","author":"Murphy","year":"2022","unstructured":"Murphy SNNguyen BASingh RBrown NJShahrestani SNeal MTPatel NP & Kalani MA. A brief human history of ankylosing spondylitis: a scoping review of pathogenesis, diagnosis, and treatment. Surgical Neurology International 2022 13 297. (https:\/\/doi.org\/10.25259\/SNI_294_2022)"},{"key":"bib78","series-title":"Nature Reviews","first-page":"387","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","unstructured":"Mauro DThomas RGuggino GLories RBrown MA & Ciccia F. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nature Reviews 2021 17 387\u2013404. (https:\/\/doi.org\/10.1038\/s41584-021-00625-y)"},{"key":"bib79","series-title":"Journal of Autoimmunity","first-page":"128","article-title":"The classification and diagnostic criteria of ankylosing spondylitis","volume":"48\u201349","author":"Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SP & Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. Journal of Autoimmunity 2014 48\u201349 128\u2013133. (https:\/\/doi.org\/10.1016\/j.jaut.2014.01.015)"},{"key":"bib80","series-title":"International Journal of Genomics","first-page":"2308585","article-title":"Gene variation of endoplasmic reticulum aminopeptidases 1 and 2, and risk of blood pressure progression and incident hypertension among 17,255 initially healthy women","volume":"2018","author":"Zee","year":"2018","unstructured":"Zee RYLRivera AInostroza YRidker PMChasman DI & Romero JR. Gene variation of endoplasmic reticulum aminopeptidases 1 and 2, and risk of blood pressure progression and incident hypertension among 17,255 initially healthy women. International Journal of Genomics 2018 2018 2308585. (https:\/\/doi.org\/10.1155\/2018\/2308585)"},{"key":"bib81","series-title":"Annals of Palliative Medicine","first-page":"2279","article-title":"Drug treatment of ankylosing spondylitis and related complications: an overlook review","volume":"9","author":"Wang","year":"2020","unstructured":"Wang HZheng H & Ma Y. Drug treatment of ankylosing spondylitis and related complications: an overlook review. Annals of Palliative Medicine 2020 9 2279\u20132285. (https:\/\/doi.org\/10.21037\/apm-20-277)"},{"key":"bib82","series-title":"Arthritis Care and Research","first-page":"1285","article-title":"Update of the American College of Rheumatology","volume":"71","author":"Ward","year":"2019","unstructured":"Ward MMDeodhar AGensler LSDubreuil MYu DKhan MAHaroon NBorenstein DWang RBiehl A, et al. Update of the American College of Rheumatology. Arthritis Care and Research: Spondylitis Association of America 2019 71 1285\u20131299. (https:\/\/doi.org\/10.1002\/acr.24025)"},{"key":"bib83","series-title":"Journal of Clinical Rheumatology","first-page":"288","article-title":"How does smoking cessation affect disease activity, function loss, and quality of life in smokers with ankylosing spondylitis?","volume":"25","author":"D\u00fclger","year":"2019","unstructured":"D\u00fclger SAykurt Karlibel \u0130Kasapo\u011flu Aksoy MAltan L\u015eeng\u00f6ren Diki\u015f \u00d6 & Yildiz T. How does smoking cessation affect disease activity, function loss, and quality of life in smokers with ankylosing spondylitis? Journal of Clinical Rheumatology 2019 25 288\u2013296. (https:\/\/doi.org\/10.1097\/RHU.0000000000000851)"},{"key":"bib84","series-title":"Modern Rheumatology","first-page":"331","article-title":"Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis","volume":"24","author":"Huang","year":"2014","unstructured":"Huang JSong GYin ZLuo X & Ye Z. Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis. Modern Rheumatology 2014 24 331\u2013334. (https:\/\/doi.org\/10.3109\/14397595.2013.854077)"},{"key":"bib85","series-title":"Clinical Laboratory","first-page":"955","article-title":"MiR-29a and messenger RNA expression of bone turnover markers in canonical Wnt pathway in patients with ankylosing spondylitis","volume":"63","author":"Huang","year":"2017","unstructured":"Huang JSong GYin ZFu Z & Ye Z. MiR-29a and messenger RNA expression of bone turnover markers in canonical Wnt pathway in patients with ankylosing spondylitis. Clinical Laboratory 2017 63 955\u2013960. (https:\/\/doi.org\/10.7754\/Clin.Lab.2017.161214)"},{"key":"bib86","series-title":"Advances in Clinical and Experimental Medicine","first-page":"1293","article-title":"miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt\/\u03b2-catenin signaling pathway","volume":"28","author":"Zhang","year":"2019","unstructured":"Zhang FCao KDu GZhang Q & Yin Z. miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt\/\u03b2-catenin signaling pathway. Advances in Clinical and Experimental Medicine 2019 28 1293\u20131300. (https:\/\/doi.org\/10.17219\/acem\/104533)"},{"key":"bib87","series-title":"Journal of Rheumatology","first-page":"1104","article-title":"Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration","volume":"41","author":"Huang","year":"2014","unstructured":"Huang CHWei JCCChang WCChiou SYChou CHLin YJHung PH & Wong RH. Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. Journal of Rheumatology 2014 41 1104\u20131111. (https:\/\/doi.org\/10.3899\/jrheum.130515)"},{"key":"bib88","series-title":"European Review for Medical and Pharmacological Sciences","first-page":"6616","article-title":"MiR-124 regulates osteoblast differentiation through GSK-3\u03b2 in ankylosing spondylitis","volume":"22","author":"Tang","year":"2018","unstructured":"Tang SLHuang QHWu LGLiu C & Cai AL. MiR-124 regulates osteoblast differentiation through GSK-3\u03b2 in ankylosing spondylitis. European Review for Medical and Pharmacological Sciences 2018 22 6616\u20136624. (https:\/\/doi.org\/10.26355\/eurrev_201810_16136)"},{"key":"bib89","series-title":"Molecular Therapy","first-page":"696","article-title":"miR-17-5p regulates heterotopic ossification by targeting ANKH in ankylosing spondylitis","volume":"18","author":"Qin","year":"2019","unstructured":"Qin XZhu BJiang TTan JWu ZYuan ZZheng L & Zhao J. miR-17-5p regulates heterotopic ossification by targeting ANKH in ankylosing spondylitis. Molecular Therapy 2019 18 696\u2013707. (https:\/\/doi.org\/10.1016\/j.omtn.2019.10.003)"},{"key":"bib90","series-title":"Medicine","first-page":"e3325","article-title":"The role of microRNAs in ankylosing spondylitis","volume":"95","author":"Li","year":"2016","unstructured":"Li ZWong SHShen JChan MTV & Wu WKK. The role of microRNAs in ankylosing spondylitis. Medicine 2016 95 e3325. (https:\/\/doi.org\/10.1097\/MD.0000000000003325)"},{"key":"bib91","series-title":"EBiomedicine","first-page":"104055","article-title":"Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies","volume":"80","author":"Wang","year":"2022","unstructured":"Wang YWei JZhang WDoherty MZhang YXie HLi WWang NLei G & Zeng C. Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies. EBiomedicine 2022 80 104055. (https:\/\/doi.org\/10.1016\/j.ebiom.2022.104055)"},{"key":"bib92","series-title":"Pharmacogenetics and Genomics","first-page":"247","article-title":"Association of Anti-TNF-\u03b1 treatment with gut microbiota of patients with ankylosing spondylitis","volume":"32","author":"Dai","year":"2022","unstructured":"Dai QXia XHe CHuang YChen YWu YChen YHou QShu YZhang W, et al. Association of Anti-TNF-\u03b1 treatment with gut microbiota of patients with ankylosing spondylitis. Pharmacogenetics and Genomics 2022 32 247\u2013256. (https:\/\/doi.org\/10.1097\/FPC.0000000000000468)"},{"key":"bib93","series-title":"Frontiers in Immunology","first-page":"762580","article-title":"Indole-3-acetic acid alters intestinal microbiota and alleviates ankylosing spondylitis in mice","volume":"13","author":"Shen","year":"2022","unstructured":"Shen JYang LYou KChen TSu ZCui ZWang MZhang WLiu BZhou K, et al. Indole-3-acetic acid alters intestinal microbiota and alleviates ankylosing spondylitis in mice. Frontiers in Immunology 2022 13 762580. (https:\/\/doi.org\/10.3389\/fimmu.2022.762580)"},{"key":"bib94","series-title":"Autoimmunity Reviews","first-page":"102827","article-title":"Gut microbiota-microRNA interactions in ankylosing spondylitis","volume":"20","author":"Tavasolian","year":"2021","unstructured":"Tavasolian F & Inman RD. Gut microbiota-microRNA interactions in ankylosing spondylitis. Autoimmunity Reviews 2021 20 102827. (https:\/\/doi.org\/10.1016\/j.autrev.2021.102827)"},{"key":"bib95","series-title":"Spine","first-page":"1668","article-title":"Prevalence, concomitance, and distribution of ossification of the spinal ligaments: results of whole spine CT scans in 1500 Japanese patients","volume":"41","author":"Fujimori","year":"2016","unstructured":"Fujimori TWatabe TIwamoto YHamada SIwasaki M & Oda T. Prevalence, concomitance, and distribution of ossification of the spinal ligaments: results of whole spine CT scans in 1500 Japanese patients. Spine 2016 41 1668\u20131676. (https:\/\/doi.org\/10.1097\/BRS.0000000000001643)"},{"key":"bib96","series-title":"BMC Musculoskeletal Disorders","first-page":"253","article-title":"Epidemiology of ossification of the spinal ligaments and associated factors in the Chinese population: a cross-sectional study of 2000 consecutive individuals","volume":"20","author":"Liang","year":"2019","unstructured":"Liang HLiu GLu SChen SJiang DShi H & Fei Q. Epidemiology of ossification of the spinal ligaments and associated factors in the Chinese population: a cross-sectional study of 2000 consecutive individuals. BMC Musculoskeletal Disorders 2019 20 253. (https:\/\/doi.org\/10.1186\/s12891-019-2569-1)"},{"key":"bib97","series-title":"Orthopaedic Surgery","first-page":"1055","article-title":"Potential link between ossification of nuchal ligament and the risk of cervical ossification of posterior longitudinal ligament: evidence and clinical implication from a meta-analysis of 8429 participants","volume":"13","author":"Zhang","year":"2021","unstructured":"Zhang BChen GGao X & Chen Z. Potential link between ossification of nuchal ligament and the risk of cervical ossification of posterior longitudinal ligament: evidence and clinical implication from a meta-analysis of 8429 participants. Orthopaedic Surgery 2021 13 1055\u20131066. (https:\/\/doi.org\/10.1111\/os.12938)"},{"key":"bib98","series-title":"Journal of the American Academy of Orthopaedic Surgeons","first-page":"820","article-title":"Ossification of the posterior longitudinal ligament: pathophysiology, diagnosis, and management","volume":"30","author":"Le","year":"2022","unstructured":"Le HVWick JBVan BW & Klineberg EO. Ossification of the posterior longitudinal ligament: pathophysiology, diagnosis, and management. Journal of the American Academy of Orthopaedic Surgeons 2022 30 820\u2013830. (https:\/\/doi.org\/10.5435\/JAAOS-D-22-00049)"},{"key":"bib99","series-title":"Scientific Reports","first-page":"9313","article-title":"Ossification of the ligamentum flavum in a nineteenth-century skeletal population sample from Ireland: using bioarchaeology to reveal a neglected spine pathology","volume":"8","author":"Geber","year":"2018","unstructured":"Geber J & Hammer N. Ossification of the ligamentum flavum in a nineteenth-century skeletal population sample from Ireland: using bioarchaeology to reveal a neglected spine pathology. Scientific Reports 2018 8 9313. (https:\/\/doi.org\/10.1038\/s41598-018-27522-x)"},{"key":"bib100","series-title":"Neurosurgical Focus","first-page":"E10","article-title":"Ossification of the posterior longitudinal ligament: pathogenesis, management, and current surgical approaches: a review","volume":"30","author":"Smith","year":"2011","unstructured":"Smith ZABuchanan CCRaphael D & Khoo LT. Ossification of the posterior longitudinal ligament: pathogenesis, management, and current surgical approaches: a review. Neurosurgical Focus 2011 30 E10. (https:\/\/doi.org\/10.3171\/2011.1.FOCUS10256)"},{"key":"bib101","series-title":"International Journal of Molecular Sciences","first-page":"13479","article-title":"Molecular and genetic mechanisms of spinal stenosis formation: systematic review","volume":"23","author":"Byvaltsev","year":"2022","unstructured":"Byvaltsev VAKalinin AAHernandez PAShepelev VVPestryakov YYAliyev MA & Giers MB. Molecular and genetic mechanisms of spinal stenosis formation: systematic review. International Journal of Molecular Sciences 2022 23 13479. (https:\/\/doi.org\/10.3390\/ijms232113479)"},{"key":"bib102","series-title":"Spine Journal","first-page":"1287","article-title":"Dyslipidemia as a novel risk for the development of symptomatic ossification of the posterior longitudinal ligament","volume":"23","author":"Fukada","year":"2023","unstructured":"Fukada SEndo TTakahata MKanayama MKoike YFujita RSuzuki RMurakami THasegawa TTerkawi MA, et al. Dyslipidemia as a novel risk for the development of symptomatic ossification of the posterior longitudinal ligament. Spine Journal 2023 23 1287\u20131295. (https:\/\/doi.org\/10.1016\/j.spinee.2023.05.005)"},{"key":"bib103","series-title":"Ortopedia, Traumatologia, Rehabilitacja","first-page":"495","article-title":"Contemporary views on the ossification of the ligamenta flava","volume":"14","author":"K\u0142osi\u0144ski","year":"2012","unstructured":"K\u0142osi\u0144ski MSkrzat JWalocha J & Mizia E. Contemporary views on the ossification of the ligamenta flava. Ortopedia, Traumatologia, Rehabilitacja 2012 14 495\u2013503. (https:\/\/doi.org\/10.5604\/15093492.1024716)"},{"key":"bib104","series-title":"Neurosurgical Focus","first-page":"E2","article-title":"Conservative management of ossification of the posterior longitudinal ligament. A review","volume":"30","author":"Pham","year":"2011","unstructured":"Pham MHAttenello FJLucas JHe SStapleton CJ & Hsieh PC. Conservative management of ossification of the posterior longitudinal ligament. A review. Neurosurgical Focus 2011 30 E2. (https:\/\/doi.org\/10.3171\/2011.1.FOCUS10273)"},{"key":"bib105","series-title":"Neurosurgical Focus","first-page":"E1","article-title":"Ossification of the posterior longitudinal ligament: a review","volume":"30","author":"Saetia","year":"2011","unstructured":"Saetia KCho DLee SKim DH & Kim SD. Ossification of the posterior longitudinal ligament: a review. Neurosurgical Focus 2011 30 E1. (https:\/\/doi.org\/10.3171\/2010.11.focus10276)"},{"key":"bib106","series-title":"Journal of the American Academy of Orthopaedic Surgeons","first-page":"e842","article-title":"Ossified ligamentum flavum: epidemiology, treatment, and outcomes","volume":"30","author":"Daniels","year":"2022","unstructured":"Daniels AHMcDonald CLBasques BA & Kuris EO. Ossified ligamentum flavum: epidemiology, treatment, and outcomes. Journal of the American Academy of Orthopaedic Surgeons 2022 30 e842\u2013e851. (https:\/\/doi.org\/10.5435\/JAAOS-D-21-01253)"},{"key":"bib107","series-title":"Biochemical Journal","first-page":"2249","article-title":"Methylation-mediated down-regulation of microRNA-497-195 cluster confers osteogenic differentiation in ossification of the posterior longitudinal ligament of the spine via ADORA2A","volume":"477","author":"Jiang","year":"2020","unstructured":"Jiang AWang NJiang YYan XChen GChi HKong PRen HXia SJi Y, et al. Methylation-mediated down-regulation of microRNA-497-195 cluster confers osteogenic differentiation in ossification of the posterior longitudinal ligament of the spine via ADORA2A. Biochemical Journal 2020 477 2249\u20132261. (https:\/\/doi.org\/10.1042\/BCJ20200157)"},{"key":"bib108","series-title":"Medicine","first-page":"e20268","article-title":"Integrated miRNA-mRNA network revealing the key molecular characteristics of ossification of the posterior longitudinal ligament","volume":"99","author":"Xu","year":"2020","unstructured":"Xu GLiu CLiang TQin ZYu CJZhang ZJiang JChen J & Zhan X. Integrated miRNA-mRNA network revealing the key molecular characteristics of ossification of the posterior longitudinal ligament. Medicine 2020 99 e20268. (https:\/\/doi.org\/10.1097\/MD.0000000000020268)"},{"key":"bib109","series-title":"Scientific Reports","first-page":"21580","article-title":"Integrated microRNA-mRNA analyses reveal OPLL specific microRNA regulatory network using high-throughput sequencing","volume":"6","author":"Xu","year":"2016","unstructured":"Xu CChen YZhang HChen YShen XShi CLiu Y & Yuan W. Integrated microRNA-mRNA analyses reveal OPLL specific microRNA regulatory network using high-throughput sequencing. Scientific Reports 2016 6 21580. (https:\/\/doi.org\/10.1038\/srep21580)"},{"key":"bib110","series-title":"Calcified Tissue International","first-page":"670","article-title":"Long non-coding RNA XIST may influence cervical ossification of the posterior longitudinal ligament through regulation of miR-17-5P\/AHNAK\/BMP2 signaling pathway","volume":"105","author":"Liao","year":"2019","unstructured":"Liao XTang DYang HChen YChen DJia LYang L & Chen X. Long non-coding RNA XIST may influence cervical ossification of the posterior longitudinal ligament through regulation of miR-17-5P\/AHNAK\/BMP2 signaling pathway. Calcified Tissue International 2019 105 670\u2013680. (https:\/\/doi.org\/10.1007\/s00223-019-00608-y)"},{"key":"bib111","series-title":"PLoS One","first-page":"e0159756","article-title":"Association of miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ossification of the posterior longitudinal ligament of the cervical spine","volume":"11","author":"Lim","year":"2016","unstructured":"Lim JJShin DAJeon YJKumar HSohn SMin HSLee JBKuh SUKim KNKim JO, et al. Association of miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ossification of the posterior longitudinal ligament of the cervical spine. PLoS One 2016 11 e0159756. (https:\/\/doi.org\/10.1371\/journal.pone.0159756)"},{"key":"bib112","series-title":"Spine Journal","first-page":"735","article-title":"MicroRNA-10a, -210, and -563 as circulating biomarkers for ossification of the posterior longitudinal ligament","volume":"19","author":"Xu","year":"2019","unstructured":"Xu CZhang HZhou WWu HShen XChen YLiao MLiu Y & Yuan W. MicroRNA-10a, -210, and -563 as circulating biomarkers for ossification of the posterior longitudinal ligament. Spine Journal 2019 19 735\u2013743. (https:\/\/doi.org\/10.1016\/j.spinee.2018.10.008)"},{"key":"bib113","series-title":"Aging","first-page":"20192","article-title":"Hsa-circ-0007292 promotes the osteogenic differentiation of posterior longitudinal ligament cells via regulating SATB2 by sponging miR-508-3p","volume":"13","author":"Jiang","year":"2021","unstructured":"Jiang AWang NYan XJiang YSong CChi HChen GWu FJi Y & Yan J. Hsa-circ-0007292 promotes the osteogenic differentiation of posterior longitudinal ligament cells via regulating SATB2 by sponging miR-508-3p. Aging 2021 13 20192\u201320217. (https:\/\/doi.org\/10.18632\/aging.203381)"},{"key":"bib114","series-title":"Journal of Orthopaedic Science","first-page":"26","article-title":"Wnt signaling pathway correlates with ossification of the spinal ligament: a microRNA array and immunohistochemical study","volume":"23","author":"Yayama","year":"2018","unstructured":"Yayama TMori KOkumura NNishizawa KKumagai KNakamura A & Imai S. Wnt signaling pathway correlates with ossification of the spinal ligament: a microRNA array and immunohistochemical study. Journal of Orthopaedic Science 2018 23 26\u201331. (https:\/\/doi.org\/10.1016\/j.jos.2017.09.024)"},{"key":"bib115","series-title":"Scientific Reports","first-page":"9225","article-title":"The microRNA-10a\/ID3\/RUNX2 axis modulates the development of ossification of Posterior Longitudinal ligament","volume":"8","author":"Xu","year":"2018","unstructured":"Xu CZhang HGu WWu HChen YZhou WSun BShen XZhang ZWang Y, et al. The microRNA-10a\/ID3\/RUNX2 axis modulates the development of ossification of Posterior Longitudinal ligament. Scientific Reports 2018 8 9225. (https:\/\/doi.org\/10.1038\/s41598-018-27514-x)"},{"key":"bib116","series-title":"Theranostics","first-page":"7492","article-title":"MicroRNA-181 regulates the development of ossification of posterior longitudinal ligament via epigenetic modulation by targeting PBX1","volume":"10","author":"Liu","year":"2020","unstructured":"Liu NZhang ZLi LShen XSun BWang RZhong HShi QWei LZhang Y, et al. MicroRNA-181 regulates the development of ossification of posterior longitudinal ligament via epigenetic modulation by targeting PBX1. Theranostics 2020 10 7492\u20137509. (https:\/\/doi.org\/10.7150\/thno.44309)"},{"key":"bib117","series-title":"Life Sciences","first-page":"119481","article-title":"Bone marrow mesenchymal stem cell-derived extracellular vesicles containing miR-497-5p inhibit RSPO2 and accelerate OPLL","volume":"279","author":"Chen","year":"2021","unstructured":"Chen XWang SCui Z & Gu Y. Bone marrow mesenchymal stem cell-derived extracellular vesicles containing miR-497-5p inhibit RSPO2 and accelerate OPLL. Life Sciences 2021 279 119481. (https:\/\/doi.org\/10.1016\/j.lfs.2021.119481)"},{"key":"bib118","series-title":"Nature Communications","first-page":"2467","article-title":"Small extracellular vesicle-mediated miR-320e transmission promotes osteogenesis in OPLL by targeting TAK1","volume":"13","author":"Xu","year":"2022","unstructured":"Xu CZhang ZLiu NLi LZhong HWang RShi QZhang ZWei LHu B, et al. Small extracellular vesicle-mediated miR-320e transmission promotes osteogenesis in OPLL by targeting TAK1. Nature Communications 2022 13 2467. (https:\/\/doi.org\/10.1038\/s41467-022-29029-6)"},{"key":"bib119","series-title":"Chinese Journal of Surgery","first-page":"203","article-title":"MicroRNA-563 promotes the osteogenic differentiation of posterior longitudinal ligament cells by inhibiting SMURF1","volume":"55","author":"Zhang","year":"2017","unstructured":"Zhang HXu CLiu Y & Yuan W. MicroRNA-563 promotes the osteogenic differentiation of posterior longitudinal ligament cells by inhibiting SMURF1. Chinese Journal of Surgery 2017 55 203\u2013207. (https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5815.2017.03.008)"},{"key":"bib120","series-title":"Bone","first-page":"305","article-title":"Long non-coding RNA MALAT1 functions as miR-1 sponge to regulate connexin 43-mediated ossification of the posterior longitudinal ligament","volume":"127","author":"Yuan","year":"2019","unstructured":"Yuan XGuo YChen DLuo YChen DMiao J & Chen Y. Long non-coding RNA MALAT1 functions as miR-1 sponge to regulate connexin 43-mediated ossification of the posterior longitudinal ligament. Bone 2019 127 305\u2013314. (https:\/\/doi.org\/10.1016\/j.bone.2019.06.019)"},{"key":"bib121","series-title":"International Journal of Molecular Sciences","first-page":"1370","article-title":"MiR-132-3p regulates the osteogenic differentiation of thoracic ligamentum flavum cells by inhibiting multiple osteogenesis-related genes","volume":"17","author":"Qu","year":"2016","unstructured":"Qu XChen ZFan DSun C & Zeng Y. MiR-132-3p regulates the osteogenic differentiation of thoracic ligamentum flavum cells by inhibiting multiple osteogenesis-related genes. International Journal of Molecular Sciences 2016 17 1370. (https:\/\/doi.org\/10.3390\/ijms17081370)"},{"key":"bib122","series-title":"Cell Biology International","first-page":"779","article-title":"MiR-615-3p inhibits the osteogenic differentiation of human lumbar ligamentum flavum cells via suppression of osteogenic regulators GDF5 and FOXO1","volume":"41","author":"Yin","year":"2017","unstructured":"Yin JZhuang GZhu YHu XZhao HZhang RGuo HFan X & Cao Y. MiR-615-3p inhibits the osteogenic differentiation of human lumbar ligamentum flavum cells via suppression of osteogenic regulators GDF5 and FOXO1. Cell Biology International 2017 41 779\u2013786. (https:\/\/doi.org\/10.1002\/cbin.10780)"},{"key":"bib123","series-title":"Journal of Cellular and Molecular Medicine","first-page":"1159","article-title":"MiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway","volume":"21","author":"Qu","year":"2017","unstructured":"Qu XChen ZFan DSun CZeng YGuo ZQi Q & Li W. MiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway. Journal of Cellular and Molecular Medicine 2017 21 1159\u20131170. (https:\/\/doi.org\/10.1111\/jcmm.13047)"},{"key":"bib124","series-title":"Molecular Therapy. Nucleic Acids","first-page":"872","article-title":"A transcriptome-level study identifies changing expression profiles for ossification of the ligamentum flavum of the spine","volume":"12","author":"Han","year":"2018","unstructured":"Han YHong YLi LLi TZhang ZWang JXia HTang YShi ZHan X, et al. A transcriptome-level study identifies changing expression profiles for ossification of the ligamentum flavum of the spine. Molecular Therapy. Nucleic Acids 2018 12 872\u2013883. (https:\/\/doi.org\/10.1016\/j.omtn.2018.07.018)"},{"key":"bib125","series-title":"FEBS Letters","first-page":"4051","article-title":"miR-342-3p promotes osteogenic differentiation via targeting ATF3","volume":"592","author":"Han","year":"2018","unstructured":"Han YZhang KHong YWang JLiu QZhang ZXia HTang YLi TLi L, et al. miR-342-3p promotes osteogenic differentiation via targeting ATF3. FEBS Letters 2018 592 4051\u20134065. (https:\/\/doi.org\/10.1002\/1873-3468.13282)"},{"key":"bib126","series-title":"Experimental Cell Research","first-page":"119","article-title":"Overexpression of miR-182 inhibits ossification of ligamentum flavum cells by targeting NAMPT","volume":"367","author":"Zhang","year":"2018","unstructured":"Zhang QShen YJiang YZhao SZhou D & Xu N. Overexpression of miR-182 inhibits ossification of ligamentum flavum cells by targeting NAMPT. Experimental Cell Research 2018 367 119\u2013131. (doi:. (https:\/\/doi.org\/10.1016\/j.yexcr.2018.03.008)"},{"key":"bib127","series-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi","first-page":"386","article-title":"Research progress of traumatic heterotopic ossification","volume":"36","author":"Cao","year":"2022","unstructured":"Cao G & Pei F. Research progress of traumatic heterotopic ossification. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2022 36 386\u2013394. (https:\/\/doi.org\/10.7507\/1002-1892.202110078)"},{"key":"bib128","series-title":"Biochemical and Biophysical Research Communications","first-page":"100","article-title":"Osteostatin improves the osteogenic differentiation of mesenchymal stem cells and enhances angiogenesis through HIF-1\u03b1 under hypoxia conditions in vitro","volume":"606","author":"Wu","year":"2022","unstructured":"Wu DLiu LFu S & Zhang J. Osteostatin improves the osteogenic differentiation of mesenchymal stem cells and enhances angiogenesis through HIF-1\u03b1 under hypoxia conditions in vitro. Biochemical and Biophysical Research Communications 2022 606 100\u2013107. (https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.085)"},{"key":"bib129","series-title":"Bone","first-page":"22","article-title":"Is heterotopic ossification getting nervous?: the role of the peripheral nervous system in heterotopic ossification","volume":"109","author":"Davis","year":"2018","unstructured":"Davis ELDavis ARGugala Z & Olmsted-Davis EA. Is heterotopic ossification getting nervous?: the role of the peripheral nervous system in heterotopic ossification. Bone 2018 109 22\u201327. (https:\/\/doi.org\/10.1016\/j.bone.2017.07.016)"},{"key":"bib130","series-title":"Clinical Orthopaedics and Related Research","first-page":"2814","article-title":"What risk factors predict recurrence of heterotopic ossification after excision in combat-related amputations?","volume":"473","author":"Pavey","year":"2015","unstructured":"Pavey GJPolfer EMNappo KETintle SMForsberg JA & Potter BK. What risk factors predict recurrence of heterotopic ossification after excision in combat-related amputations? Clinical Orthopaedics and Related Research 2015 473 2814\u20132824. (https:\/\/doi.org\/10.1007\/s11999-015-4266-1)"},{"key":"bib131","series-title":"Calcified Tissue International","first-page":"196","article-title":"NSAIDs for prophylaxis for heterotopic ossification after total hip arthroplasty: A bayesian network meta-analysis","volume":"108","author":"Migliorini","year":"2021","unstructured":"Migliorini FTrivellas AEschweiler JDriessen ATingart M & Maffulli N. NSAIDs for prophylaxis for heterotopic ossification after total hip arthroplasty: A bayesian network meta-analysis. Calcified Tissue International 2021 108 196\u2013206. (https:\/\/doi.org\/10.1007\/s00223-020-00763-7)"},{"key":"bib132","series-title":"Scientific Reports","first-page":"22729","article-title":"MiR-630 inhibits endothelial-mesenchymal transition by targeting slug in traumatic heterotopic ossification","volume":"6","author":"Sun","year":"2016","unstructured":"Sun YCai JYu SChen SLi F & Fan C. MiR-630 inhibits endothelial-mesenchymal transition by targeting slug in traumatic heterotopic ossification. Scientific Reports 2016 6 22729. (https:\/\/doi.org\/10.1038\/srep22729)"},{"key":"bib133","series-title":"Bone","first-page":"116883","article-title":"Coding and noncoding RNA profile of human heterotopic ossifications - Risk factors and biomarkers","volume":"176","author":"Mierzejewski","year":"2023","unstructured":"Mierzejewski BPulik \u0141Grabowska ISibilska ACiemerych MA\u0141\u0119gosz P & Brzoska E. Coding and noncoding RNA profile of human heterotopic ossifications - Risk factors and biomarkers. Bone 2023 176 116883. (https:\/\/doi.org\/10.1016\/j.bone.2023.116883)"},{"key":"bib134","series-title":"Journal of Bone and Joint Surgery. American Volume","first-page":"1891","article-title":"A microRNA signature for impaired wound-healing and ectopic bone formation in humans","volume":"102","author":"de Vasconcellos","year":"2020","unstructured":"de Vasconcellos JFJackson WMDimtchev A & Nesti LJ. A microRNA signature for impaired wound-healing and ectopic bone formation in humans. Journal of Bone and Joint Surgery. American Volume 2020 102 1891\u20131899. (https:\/\/doi.org\/10.2106\/JBJS.19.00896)"},{"key":"bib135","series-title":"PLoS One","first-page":"e56641","article-title":"Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells","volume":"8","author":"Oishi","year":"2013","unstructured":"Oishi TUezumi AKanaji AYamamoto NYamaguchi AYamada H & Tsuchida K. Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells. PLoS One 2013 8 e56641. (https:\/\/doi.org\/10.1371\/journal.pone.0056641)"},{"key":"bib136","series-title":"Chemistry and Biodiversity","first-page":"e202301972","article-title":"Exosome MiR-21-5p upregulated by HIF-1\u03b1 induces adipose stem cell differentiation to promote ectopic bone formation","volume":"21","author":"Wang","year":"2024","unstructured":"Wang PLiu BSong CJia JWang YPang KWang Y & Chen C. Exosome MiR-21-5p upregulated by HIF-1\u03b1 induces adipose stem cell differentiation to promote ectopic bone formation. Chemistry and Biodiversity 2024 21 e202301972. (https:\/\/doi.org\/10.1002\/cbdv.202301972)"},{"key":"bib137","series-title":"Cell Death and Disease","first-page":"e2436","article-title":"miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2","volume":"7","author":"Tu","year":"2016","unstructured":"Tu BLiu SYu BZhu JRuan HTang T & Fan C. miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2. Cell Death and Disease 2016 7 e2436. (https:\/\/doi.org\/10.1038\/cddis.2016.325)"},{"key":"bib138","series-title":"Journal of Molecular Cell Biology","first-page":"305","article-title":"Overexpression of mechanical sensitive miR-337-3p alleviates ectopic ossification in rat tendinopathy model via targeting IRS1 and Nox4 of tendon-derived stem cells","volume":"12","author":"Geng","year":"2020","unstructured":"Geng YZhao XXu JZhang XHu GFu SCDai KChen XPatrick YSH & Zhang X. Overexpression of mechanical sensitive miR-337-3p alleviates ectopic ossification in rat tendinopathy model via targeting IRS1 and Nox4 of tendon-derived stem cells. Journal of Molecular Cell Biology 2020 12 305\u2013317. (https:\/\/doi.org\/10.1093\/jmcb\/mjz030)"},{"key":"bib139","series-title":"Brain Injury","first-page":"1727","article-title":"Heterotopic ossification as rare complication of hemiplegia following stroke: two cases","volume":"27","author":"Gurcay","year":"2013","unstructured":"Gurcay EOzturk EAErdem TGurcay AG & Cakci A. Heterotopic ossification as rare complication of hemiplegia following stroke: two cases. Brain Injury 2013 27 1727\u20131731. (https:\/\/doi.org\/10.3109\/02699052.2013.831123)"},{"key":"bib140","series-title":"Brain Injury","first-page":"866","article-title":"Troublesome heterotopic ossification and stroke: features and risk factors: a case control study","volume":"29","author":"Gen\u00eat","year":"2015","unstructured":"Gen\u00eat FMinooee KJourdan CRuet ADenormandie P & Schnitzler A. Troublesome heterotopic ossification and stroke: features and risk factors: a case control study. Brain Injury 2015 29 866\u2013871. (https:\/\/doi.org\/10.3109\/02699052.2015.1005133)"},{"key":"bib141","series-title":"Oxidative Medicine and Cellular Longevity","first-page":"7663366","article-title":"Single-cell integration analysis of heterotopic ossification and fibrocartilage developmental lineage: endoplasmic reticulum stress effector Xbp1 transcriptionally regulates the Notch signaling pathway to mediate fibrocartilage differentiation","volume":"2021","author":"Chen","year":"2021","unstructured":"Chen YSun YXu YLin WWLuo ZHan ZLiu SQi BSun CGo K, et al. Single-cell integration analysis of heterotopic ossification and fibrocartilage developmental lineage: endoplasmic reticulum stress effector Xbp1 transcriptionally regulates the Notch signaling pathway to mediate fibrocartilage differentiation. Oxidative Medicine and Cellular Longevity 2021 2021 7663366. (https:\/\/doi.org\/10.1155\/2021\/7663366)"},{"key":"bib142","series-title":"Communications Biology","first-page":"932","article-title":"Spinal cord injury dysregulates fibro-adipogenic progenitors miRNAs signaling to promote neurogenic heterotopic ossifications","volume":"6","author":"Gueguen","year":"2023","unstructured":"Gueguen JGirard DRival BFernandez JGoriot ME & Banzet S. Spinal cord injury dysregulates fibro-adipogenic progenitors miRNAs signaling to promote neurogenic heterotopic ossifications. Communications Biology 2023 6 932. (https:\/\/doi.org\/10.1038\/s42003-023-05316-w)"},{"key":"bib143","series-title":"Blood","first-page":"3648","article-title":"A microRNA expression s","volume":"117","author":"Sugatani","year":"2011","unstructured":"Sugatani TVacher J & Hruska KA. A microRNA expression signature of osteoclastogenesis. Blood 2011 117 3648\u20133657. (https:\/\/doi.org\/10.1182\/blood-2010-10-311415)"},{"key":"bib144","series-title":"Biochemical and Biophysical Research Communications","first-page":"928","article-title":"MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1\/5\/8-Runx2 pathway","volume":"493","author":"Li","year":"2017","unstructured":"Li XGuo LLiu YSu YXie YDu JZhou JDing GWang HBai Y, et al. MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1\/5\/8-Runx2 pathway. Biochemical and Biophysical Research Communications 2017 493 928\u2013933. (https:\/\/doi.org\/10.1016\/j.bbrc.2017.09.119)"},{"key":"bib145","series-title":"Journal of Extracellular Vesicles","first-page":"e12152","article-title":"Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p","volume":"10","author":"Lee","year":"2021","unstructured":"Lee KSLee JKim HKYeom SHWoo CHJung YJYun YEPark SYHan JKim E, et al. Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p. Journal of Extracellular Vesicles 2021 10 e12152. (https:\/\/doi.org\/10.1002\/jev2.12152)"},{"key":"bib146","series-title":"Materials Today","first-page":"100319","article-title":"Exosomes derived from magnetically actuated bone mesenchymal stem cells promote tendon-bone healing through the miR-21-5p\/SMAD7 pathway","volume":"15","author":"Wu","year":"2022","unstructured":"Wu XDKang LTian JWu YHuang YLiu JWang HQiu G & Wu Z. Exosomes derived from magnetically actuated bone mesenchymal stem cells promote tendon-bone healing through the miR-21-5p\/SMAD7 pathway. Materials Today 2022 15 100319. (https:\/\/doi.org\/10.1016\/j.mtbio.2022.100319)"},{"key":"bib147","series-title":"Biochemical and Biophysical Research Communications","first-page":"2555","article-title":"The role of lncRNA XIST\/miR-211 axis in modulating the proliferation and apoptosis of osteoarthritis chondrocytes through CXCR4 and MAPK signaling","volume":"503","author":"Li","year":"2018","unstructured":"Li LLv GWang B & Kuang L. The role of lncRNA XIST\/miR-211 axis in modulating the proliferation and apoptosis of osteoarthritis chondrocytes through CXCR4 and MAPK signaling. Biochemical and Biophysical Research Communications 2018 503 2555\u20132562. (https:\/\/doi.org\/10.1016\/j.bbrc.2018.07.015)"},{"key":"bib148","series-title":"Oncotarget","first-page":"113543","article-title":"Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis","volume":"8","author":"Zhang","year":"2017","unstructured":"Zhang CWang CJia ZTong WLiu DHe CHuang X & Xu W. Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis. Oncotarget 2017 8 113543\u2013113557. (https:\/\/doi.org\/10.18632\/oncotarget.22708)"},{"key":"bib149","series-title":"Biochemical and Biophysical Research Communications","first-page":"749","article-title":"miR-199b-5p modulates BMSC osteogenesis via suppressing GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"477","author":"Zhao","year":"2016","unstructured":"Zhao RLi YLin ZWan JXu CZeng Y & Zhu Y. miR-199b-5p modulates BMSC osteogenesis via suppressing GSK-3\u03b2\/\u03b2-catenin signaling pathway. Biochemical and Biophysical Research Communications 2016 477 749\u2013754. (https:\/\/doi.org\/10.1016\/j.bbrc.2016.06.130)"}],"container-title":["EFORT Open Reviews"],"original-title":[],"link":[{"URL":"https:\/\/eor.bioscientifica.com\/view\/journals\/eor\/9\/12\/EOR-22-0100.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eor.bioscientifica.com\/downloadpdf\/journals\/eor\/9\/12\/EOR-22-0100.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/eor.bioscientifica.com\/downloadpdf\/journals\/eor\/9\/12\/EOR-22-0100.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:50:53Z","timestamp":1784555453000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/eor\/article\/9\/12\/1120-1133\/2690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":149,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/eor-22-0100","relation":{},"ISSN":["2058-5241"],"issn-type":[{"value":"2058-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}